Predictmedix AI Launches Mobile Diagnostics Platform for Diabetes Screening
Predictmedix AI Inc. (CSE: PMED | OTC: PMEDF | FRA: 3QP) has entered the mobile diagnostics space by launching a direct-to-consumer diabetes screening tool. The firm has chosen India as the platform’s first market. The non-invasive s olution provides fast risk assessments via smartphones with no need for blood work or clinic visits. By combining […]